-
1
-
-
14944385553
-
Global cancer statistics
-
10.3322/canjclin.55.2.74, 15761078
-
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin 2005, 55(2):74-108. 10.3322/canjclin.55.2.74, 15761078.
-
(2005)
CA Cancer J Clin
, vol.55
, Issue.2
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
2
-
-
79958814789
-
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008
-
10.4143/crt.2011.43.1.1, 3072529, 21509157
-
Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat 2011, 43(1):1-11. 10.4143/crt.2011.43.1.1, 3072529, 21509157.
-
(2011)
Cancer Res Treat
, vol.43
, Issue.1
, pp. 1-11
-
-
Jung, K.W.1
Park, S.2
Kong, H.J.3
-
3
-
-
33745547767
-
Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data
-
10.1200/JCO.2005.05.0245, 16782930
-
Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 2006, 24(18):2903-2909. 10.1200/JCO.2005.05.0245, 16782930.
-
(2006)
J Clin Oncol
, vol.24
, Issue.18
, pp. 2903-2909
-
-
Wagner, A.D.1
Grothe, W.2
Haerting, J.3
Kleber, G.4
Grothey, A.5
Fleig, W.E.6
-
4
-
-
80054717683
-
The role of chemotherapy in metastatic gastric cancer
-
Pasini F, Fraccon AP, DEM G. The role of chemotherapy in metastatic gastric cancer. Anticancer Res 2011, 31(10):3543-3554.
-
(2011)
Anticancer Res
, vol.31
, Issue.10
, pp. 3543-3554
-
-
Pasini, F.1
Fraccon, A.P.2
Dem, G.3
-
5
-
-
34247326603
-
A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer
-
10.1080/02841860600791483, 17450469
-
Oh SY, Kwon HC, Seo BG, Kim SH, Kim JS, Kim HJ. A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer. Acta Oncol 2007, 46(3):336-341. 10.1080/02841860600791483, 17450469.
-
(2007)
Acta Oncol
, vol.46
, Issue.3
, pp. 336-341
-
-
Oh, S.Y.1
Kwon, H.C.2
Seo, B.G.3
Kim, S.H.4
Kim, J.S.5
Kim, H.J.6
-
6
-
-
79952407394
-
Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) combination chemotherapy as a salvage treatment in advanced gastric cancer
-
10.4143/crt.2010.42.1.24, 2848744, 20369048
-
Kim YS, Hong J, Sym SJ, et al. Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) combination chemotherapy as a salvage treatment in advanced gastric cancer. Cancer Res Treat 2010, 42(1):24-29. 10.4143/crt.2010.42.1.24, 2848744, 20369048.
-
(2010)
Cancer Res Treat
, vol.42
, Issue.1
, pp. 24-29
-
-
Kim, Y.S.1
Hong, J.2
Sym, S.J.3
-
7
-
-
0031039243
-
The biology of vascular endothelial growth factor
-
10.1210/er.18.1.4, 9034784
-
Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997, 18(1):4-25. 10.1210/er.18.1.4, 9034784.
-
(1997)
Endocr Rev
, vol.18
, Issue.1
, pp. 4-25
-
-
Ferrara, N.1
Davis-Smyth, T.2
-
8
-
-
0031037638
-
Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma
-
Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 1997, 15(2):826-832.
-
(1997)
J Clin Oncol
, vol.15
, Issue.2
, pp. 826-832
-
-
Tanigawa, N.1
Amaya, H.2
Matsumura, M.3
Shimomatsuya, T.4
-
9
-
-
0030066037
-
Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
-
10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A, 8608475
-
Maeda K, Chung YS, Ogawa Y, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996, 77(5):858-863. 10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A, 8608475.
-
(1996)
Cancer
, vol.77
, Issue.5
, pp. 858-863
-
-
Maeda, K.1
Chung, Y.S.2
Ogawa, Y.3
-
10
-
-
0033865580
-
Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production
-
10.1006/cyto.2000.0692, 10930302
-
Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000, 12(8):1232-1235. 10.1006/cyto.2000.0692, 10930302.
-
(2000)
Cytokine
, vol.12
, Issue.8
, pp. 1232-1235
-
-
Watson, C.J.1
Webb, N.J.2
Bottomley, M.J.3
Brenchley, P.E.4
-
11
-
-
70349499022
-
The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors
-
10.1158/1535-7163.MCT-09-0302, 2751847, 19755511
-
Jain L, Vargo CA, Danesi R, et al. The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Mol Cancer Ther 2009, 8(9):2496-2508. 10.1158/1535-7163.MCT-09-0302, 2751847, 19755511.
-
(2009)
Mol Cancer Ther
, vol.8
, Issue.9
, pp. 2496-2508
-
-
Jain, L.1
Vargo, C.A.2
Danesi, R.3
-
12
-
-
33845226536
-
Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival
-
10.1002/jso.20619, 17111394
-
Tzanakis N, Gazouli M, Rallis G, et al. Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol 2006, 94(7):624-630. 10.1002/jso.20619, 17111394.
-
(2006)
J Surg Oncol
, vol.94
, Issue.7
, pp. 624-630
-
-
Tzanakis, N.1
Gazouli, M.2
Rallis, G.3
-
13
-
-
34447295882
-
Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer
-
10.1093/annonc/mdm085, 17426061
-
Kim JG, Sohn SK, Chae YS, et al. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer. Ann Oncol 2007, 18(6):1030-1036. 10.1093/annonc/mdm085, 17426061.
-
(2007)
Ann Oncol
, vol.18
, Issue.6
, pp. 1030-1036
-
-
Kim, J.G.1
Sohn, S.K.2
Chae, Y.S.3
-
14
-
-
0036984738
-
Tumor angiogenesis and accessibility: role of vascular endothelial growth factor
-
Jain RK. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor. Semin Oncol 2002, 29(6 Suppl 16):3-9.
-
(2002)
Semin Oncol
, vol.29
, Issue.6 SUPPL. 16
, pp. 3-9
-
-
Jain, R.K.1
-
15
-
-
79151473796
-
The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer
-
10.1038/tpj.2010.4, 20125120
-
Hansen TF, Garm Spindler KL, Andersen RF, Lindebjerg J, Brandslund I, Jakobsen A. The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer. Pharmacogenomics J 2011, 11(1):53-60. 10.1038/tpj.2010.4, 20125120.
-
(2011)
Pharmacogenomics J
, vol.11
, Issue.1
, pp. 53-60
-
-
Hansen, T.F.1
Garm Spindler, K.L.2
Andersen, R.F.3
Lindebjerg, J.4
Brandslund, I.5
Jakobsen, A.6
-
16
-
-
79957510326
-
VEGF - 460 T C polymorphism and its association with VEGF expression and outcome to FOLFOX-4 treatment in patients with colorectal carcinoma
-
10.1038/tpj.2010.48, 20531372
-
Chen MH, Tzeng CH, Chen PM, et al. VEGF - 460 T C polymorphism and its association with VEGF expression and outcome to FOLFOX-4 treatment in patients with colorectal carcinoma. Pharmacogenomics J 2011, 11(3):227-236. 10.1038/tpj.2010.48, 20531372.
-
(2011)
Pharmacogenomics J
, vol.11
, Issue.3
, pp. 227-236
-
-
Chen, M.H.1
Tzeng, C.H.2
Chen, P.M.3
-
17
-
-
33847645479
-
Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer
-
Kwon HC, Roh MS, Oh SY, et al. Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer. Ann Oncol 2007, 18(3):504-509.
-
(2007)
Ann Oncol
, vol.18
, Issue.3
, pp. 504-509
-
-
Kwon, H.C.1
Roh, M.S.2
Oh, S.Y.3
-
18
-
-
68249140418
-
Comprehensive analysis of excision repair complementation group 1, glutathione S-transferase, thymidylate synthase and uridine diphosphate glucuronosyl transferase 1A1 polymorphisms predictive for treatment outcome in patients with advanced gastric cancer treated with FOLFOX or FOLFIRI
-
Seo BG, Kwon HC, Oh SY. Comprehensive analysis of excision repair complementation group 1, glutathione S-transferase, thymidylate synthase and uridine diphosphate glucuronosyl transferase 1A1 polymorphisms predictive for treatment outcome in patients with advanced gastric cancer treated with FOLFOX or FOLFIRI. Oncol Rep 2009, 22(1):127-136.
-
(2009)
Oncol Rep
, vol.22
, Issue.1
, pp. 127-136
-
-
Seo, B.G.1
Kwon, H.C.2
Oh, S.Y.3
-
19
-
-
0035187771
-
Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications
-
10.1016/S1470-2045(01)00556-3, 11902537
-
Toi M, Matsumoto T, Bando H. Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications. Lancet Oncol 2001, 2(11):667-673. 10.1016/S1470-2045(01)00556-3, 11902537.
-
(2001)
Lancet Oncol
, vol.2
, Issue.11
, pp. 667-673
-
-
Toi, M.1
Matsumoto, T.2
Bando, H.3
-
20
-
-
58149346076
-
Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab
-
10.1158/1078-0432.CCR-08-0351, 2586993, 19010874
-
Schultheis AM, Lurje G, Rhodes KE, et al. Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab. Clin Cancer Res 2008, 14(22):7554-7563. 10.1158/1078-0432.CCR-08-0351, 2586993, 19010874.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.22
, pp. 7554-7563
-
-
Schultheis, A.M.1
Lurje, G.2
Rhodes, K.E.3
-
21
-
-
53749093040
-
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100
-
10.1200/JCO.2008.16.1612, 2653128, 18824714
-
Schneider BP, Wang M, Radovich M, et al. Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. J Clin Oncol 2008, 26(28):4672-4678. 10.1200/JCO.2008.16.1612, 2653128, 18824714.
-
(2008)
J Clin Oncol
, vol.26
, Issue.28
, pp. 4672-4678
-
-
Schneider, B.P.1
Wang, M.2
Radovich, M.3
-
22
-
-
79951723590
-
Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab
-
10.1007/s00384-010-1108-1, 21188390
-
Formica V, Palmirotta R, Del Monte G, et al. Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab. Int J Colorectal Dis 2011, 26(2):143-151. 10.1007/s00384-010-1108-1, 21188390.
-
(2011)
Int J Colorectal Dis
, vol.26
, Issue.2
, pp. 143-151
-
-
Formica, V.1
Palmirotta, R.2
Del Monte, G.3
-
23
-
-
46849098774
-
Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer
-
10.3346/jkms.2008.23.3.421, 2526538, 18583877
-
Chae YS, Kim JG, Sohn SK, et al. Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer. J Korean Med Sci 2008, 23(3):421-427. 10.3346/jkms.2008.23.3.421, 2526538, 18583877.
-
(2008)
J Korean Med Sci
, vol.23
, Issue.3
, pp. 421-427
-
-
Chae, Y.S.1
Kim, J.G.2
Sohn, S.K.3
-
24
-
-
34547770379
-
Gender-specific association of the VEGF -2578C > A polymorphism in Korean patients with colon cancer
-
Park HM, Hong SH, Kim JW, et al. Gender-specific association of the VEGF -2578C > A polymorphism in Korean patients with colon cancer. Anticancer Res 2007, 27(4B):2535-2539.
-
(2007)
Anticancer Res
, vol.27
, Issue.4 B
, pp. 2535-2539
-
-
Park, H.M.1
Hong, S.H.2
Kim, J.W.3
-
25
-
-
42549161440
-
Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C > T) gene and colon cancer in Korea
-
Bae SJ, Kim JW, Kang H, Hwang SG, Oh D, Kim NK. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C > T) gene and colon cancer in Korea. Anticancer Res 2008, 28(2B):1271-1276.
-
(2008)
Anticancer Res
, vol.28
, Issue.2 B
, pp. 1271-1276
-
-
Bae, S.J.1
Kim, J.W.2
Kang, H.3
Hwang, S.G.4
Oh, D.5
Kim, N.K.6
-
26
-
-
38449109288
-
Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer
-
Fukuda H, Tsuchiya N, Narita S, et al. Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer. Oncol Rep 2007, 18(5):1155-1163.
-
(2007)
Oncol Rep
, vol.18
, Issue.5
, pp. 1155-1163
-
-
Fukuda, H.1
Tsuchiya, N.2
Narita, S.3
-
27
-
-
40749139487
-
Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer
-
10.1158/1078-0432.CCR-07-1537, 18172253
-
Kim JG, Chae YS, Sohn SK, et al. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res 2008, 14(1):62-66. 10.1158/1078-0432.CCR-07-1537, 18172253.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.1
, pp. 62-66
-
-
Kim, J.G.1
Chae, Y.S.2
Sohn, S.K.3
-
28
-
-
0035208145
-
New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation
-
10.1210/me.15.12.2197, 11731620
-
Huez I, Bornes S, Bresson D, Creancier L, Prats H. New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation. Mol Endocrinol 2001, 15(12):2197-2210. 10.1210/me.15.12.2197, 11731620.
-
(2001)
Mol Endocrinol
, vol.15
, Issue.12
, pp. 2197-2210
-
-
Huez, I.1
Bornes, S.2
Bresson, D.3
Creancier, L.4
Prats, H.5
-
29
-
-
0036316846
-
A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes
-
10.2337/diabetes.51.5.1635, 11978667
-
Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002, 51(5):1635-1639. 10.2337/diabetes.51.5.1635, 11978667.
-
(2002)
Diabetes
, vol.51
, Issue.5
, pp. 1635-1639
-
-
Awata, T.1
Inoue, K.2
Kurihara, S.3
-
30
-
-
77953348691
-
A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer
-
Kim BG, Oh SY, Kwon HC, et al. A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer. Am J Clin Oncol 2010, 33(3):246-250.
-
(2010)
Am J Clin Oncol
, vol.33
, Issue.3
, pp. 246-250
-
-
Kim, B.G.1
Oh, S.Y.2
Kwon, H.C.3
-
31
-
-
77949414964
-
Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer
-
10.1002/cncr.24925, 20108336
-
Overman MJ, Kazmi SM, Jhamb J, et al. Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer. Cancer 2010, 116(6):1446-1453. 10.1002/cncr.24925, 20108336.
-
(2010)
Cancer
, vol.116
, Issue.6
, pp. 1446-1453
-
-
Overman, M.J.1
Kazmi, S.M.2
Jhamb, J.3
|